| scholarly article | Q13442814 |
| P50 | author | Matthew J. Kempton | Q21094750 |
| Christian Benedict | Q56301861 | ||
| Samantha J Brooks | Q56917336 | ||
| Lars Lind | Q65992534 | ||
| Håkan Ahlström | Q66190621 | ||
| Lars Johansson | Q66191055 | ||
| Joel Kullberg | Q91760902 | ||
| Suzanne Craft | Q114385410 | ||
| Helgi B. Schiöth | Q30112644 | ||
| P2093 | author name string | Elna-Marie Larsson | |
| Lena Kilander | |||
| Jonathan Burgos | |||
| Richard Nordenskjöld | |||
| Ruta Nylander | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Voxel-based morphometry–the methods | Q28138780 | ||
| Dorsal and ventral streams: a framework for understanding aspects of the functional anatomy of language | Q28252051 | ||
| Use and abuse of HOMA modeling | Q28263292 | ||
| Obese men respond to cognitive but not to catabolic brain insulin signaling. | Q50888528 | ||
| A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. | Q50899873 | ||
| Automated and reproducible segmentation of visceral and subcutaneous adipose tissue from abdominal MRI. | Q51911773 | ||
| Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. | Q52027754 | ||
| Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation. | Q54633326 | ||
| Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease | Q71102940 | ||
| Low cerebrospinal fluid insulin levels in obese humans | Q80210868 | ||
| Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers | Q28308082 | ||
| Unified segmentation | Q29616050 | ||
| The anatomy of language: a review of 100 fMRI studies published in 2009. | Q33555658 | ||
| Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease | Q33940256 | ||
| Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. | Q34038935 | ||
| Visceral fat is associated with lower brain volume in healthy middle-aged adults | Q34105185 | ||
| Sniffing neuropeptides: a transnasal approach to the human brain | Q34126887 | ||
| Intranasal insulin improves memory in humans | Q34337964 | ||
| Evolution of declarative memory | Q34553104 | ||
| The assessment of insulin resistance in man. | Q34722579 | ||
| Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly | Q34763045 | ||
| The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study | Q35033208 | ||
| Brain insulin: regulation, mechanisms of action and functions | Q35110028 | ||
| Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study | Q35123326 | ||
| Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease | Q37160906 | ||
| ADDLs and the signaling web that leads to Alzheimer's disease | Q37774738 | ||
| Screening for dementia by memory testing | Q38486281 | ||
| Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? | Q39952627 | ||
| Insulin receptors are widely distributed in the central nervous system of the rat | Q40141863 | ||
| Cognitive impairment of Alzheimer disease | Q40171074 | ||
| Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. | Q41841220 | ||
| Education, occupation, leisure activities, and brain reserve: a population-based study | Q44132366 | ||
| Blood pressure, cerebral blood flow, and brain volumes. The SMART-MR study | Q46259071 | ||
| A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study | Q46686072 | ||
| Intranasal insulin improves cognition and modulates beta-amyloid in early AD. | Q46945303 | ||
| Structural brain differences and cognitive functioning related to body mass index in older females | Q48383706 | ||
| Structural brain changes and cognition in relation to markers of vascular dysfunction | Q48828492 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 488-494 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly | |
| P478 | volume | 35 |
| Q92711684 | A Metabolic Obesity Profile Is Associated With Decreased Gray Matter Volume in Cognitively Healthy Older Adults |
| Q64117428 | A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions |
| Q36912541 | A link between type 2 diabetes and brain function |
| Q34308807 | A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder |
| Q36892257 | Alterations in white matter volume and integrity in obesity and type 2 diabetes |
| Q54997126 | Alterations of White Matter Integrity and Hippocampal Functional Connectivity in Type 2 Diabetes Without Mild Cognitive Impairment. |
| Q26996487 | Alzheimer's disease and insulin resistance: translating basic science into clinical applications |
| Q36746546 | Association between adiposity and cognitive function in young men: Hormonal mechanisms |
| Q37509607 | BDNF polymorphisms are linked to poorer working memory performance, reduced cerebellar and hippocampal volumes and differences in prefrontal cortex in a Swedish elderly population |
| Q90745617 | Behavioral Abnormalities in Knockout and Humanized Tau Mice |
| Q26739671 | Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans |
| Q47835103 | Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums |
| Q33841997 | Cardiovascular risk factors and frontotemporal dementia: a case-control study |
| Q37510148 | Cerebral white matter integrity and resting-state functional connectivity in middle-aged patients with type 2 diabetes |
| Q35070855 | Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes |
| Q92749912 | Cognitive Effects of Adding Caloric Restriction to Aerobic Exercise Training in Older Adults with Obesity |
| Q54967973 | Cognitive impairment in metabolically-obese, normal-weight rats: identification of early biomarkers in peripheral blood mononuclear cells. |
| Q53346032 | Connecting type 2 diabetes to Alzheimer's disease. |
| Q92809027 | Dementia risk by combinations of metabolic diseases and body mass index: Japan Gerontological Evaluation Study Cohort Study |
| Q41995767 | Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease |
| Q45072634 | Diabetic Microvascular Disease: An Endocrine Society Scientific Statement |
| Q36993406 | Dietary intake of eicosapentaenoic and docosahexaenoic acids is linked to gray matter volume and cognitive function in elderly |
| Q59807700 | Diffusion spectrum imaging in white matter microstructure in subjects with type 2 diabetes |
| Q27009988 | Food for thought: the role of appetitive peptides in age-related cognitive decline |
| Q90718287 | GluT4: A central player in hippocampal memory and brain insulin resistance |
| Q35200837 | Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study |
| Q47570931 | Glucose regulation and face recognition deficits in older adults: the role of attention. |
| Q30845405 | Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review |
| Q93097327 | Glycated Hemoglobin, but not Insulin Sensitivity, is Associated with Memory in Subjects with Obesity |
| Q37205185 | Gray matter alterations and correlation of nutritional intake with the gray matter volume in prediabetes |
| Q90566547 | Imaging of brain glucose uptake by PET in obesity and cognitive dysfunction: life-course perspective |
| Q53685113 | Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review. |
| Q47556291 | Insulin Resistance is Associated with Cognitive Decline Among Older Koreans with Normal Baseline Cognitive Function: A Prospective Community-Based Cohort Study. |
| Q37343162 | Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults |
| Q40508985 | Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration. |
| Q38191590 | Insulin dysfunction and Tau pathology. |
| Q40285072 | Insulin resistance and cognitive performance in type 2 diabetes - The Maastricht study. |
| Q34412464 | Insulin resistance and gray matter volume in neurodegenerative disease |
| Q48146163 | Insulin resistance is associated with poorer verbal fluency performance in women. |
| Q38603015 | Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. |
| Q34429975 | Insulin resistance predicts brain amyloid deposition in late middle-aged adults. |
| Q36560342 | Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults |
| Q34357070 | Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders |
| Q64454287 | Insulin resistance: Genetic associations with depression and cognition in population based cohorts |
| Q30277159 | Intrahippocampal administration of a domain antibody that binds aggregated amyloid-β reverses cognitive deficits produced by diet-induced obesity |
| Q24601034 | Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence |
| Q48105305 | Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure. |
| Q34019193 | Is Alzheimer's disease a systemic disease? |
| Q40185396 | Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study |
| Q34110731 | Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects. |
| Q37092852 | Metabolic and endocrine correlates of cognitive function in healthy young women |
| Q30991322 | Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body |
| Q58612959 | Moderating Effect of Insulin Resistance on the Relationship between Gray Matter Volumes and Cognitive Function |
| Q59711065 | Overfed but undernourished: recognizing nutritional inadequacies/deficiencies in patients with overweight or obesity |
| Q36611401 | Relationship between Insulin-Resistance Processing Speed and Specific Executive Function Profiles in Neurologically Intact Older Adults |
| Q26784170 | Shared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive Decline |
| Q26744834 | The Rationale for Insulin Therapy in Alzheimer's Disease |
| Q27307127 | The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier? |
| Q29994562 | The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology |
| Q26824702 | Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales |
| Q37158071 | Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies |
| Q47096119 | Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease |
Search more.